IS7696A - Pýrrólídínafleiður sem trypsínhemlar - Google Patents

Pýrrólídínafleiður sem trypsínhemlar

Info

Publication number
IS7696A
IS7696A IS7696A IS7696A IS7696A IS 7696 A IS7696 A IS 7696A IS 7696 A IS7696 A IS 7696A IS 7696 A IS7696 A IS 7696A IS 7696 A IS7696 A IS 7696A
Authority
IS
Iceland
Prior art keywords
trypsin inhibitors
pyrrolidine derivatives
pyrrolidine
derivatives
trypsin
Prior art date
Application number
IS7696A
Other languages
English (en)
Inventor
Martin Thomas
Ulrich Wolf-Rüdiger
Bar Thomas
P. Sommerhoff Christian
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IS7696A publication Critical patent/IS7696A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IS7696A 2002-07-26 2005-02-17 Pýrrólídínafleiður sem trypsínhemlar IS7696A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02016683 2002-07-26
PCT/EP2003/008127 WO2004012731A1 (en) 2002-07-26 2003-07-24 Pyrrolidine derivatives as tryptase inhibitors

Publications (1)

Publication Number Publication Date
IS7696A true IS7696A (is) 2005-02-17

Family

ID=31197777

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7696A IS7696A (is) 2002-07-26 2005-02-17 Pýrrólídínafleiður sem trypsínhemlar

Country Status (10)

Country Link
US (1) US20050256171A1 (is)
EP (1) EP1534267A1 (is)
JP (1) JP2005535685A (is)
AU (1) AU2003250162A1 (is)
CA (1) CA2492830A1 (is)
HR (1) HRP20050156A2 (is)
IS (1) IS7696A (is)
PL (1) PL372826A1 (is)
RS (1) RS20050063A (is)
WO (1) WO2004012731A1 (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468724B1 (en) * 2006-12-21 2015-11-18 Zealand Pharma A/S Synthesis of pyrrolidine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509417A (ja) * 1999-09-14 2003-03-11 アルタナ ファルマ アクチエンゲゼルシャフト トリプターゼインヒビター
JP4592174B2 (ja) * 1999-11-15 2010-12-01 オセ−テクノロジーズ ビーブイ インクペレットディスペンサを有するインクジェット装置

Also Published As

Publication number Publication date
PL372826A1 (en) 2005-08-08
CA2492830A1 (en) 2004-02-12
HRP20050156A2 (en) 2005-12-31
WO2004012731A1 (en) 2004-02-12
EP1534267A1 (en) 2005-06-01
JP2005535685A (ja) 2005-11-24
AU2003250162A1 (en) 2004-02-23
US20050256171A1 (en) 2005-11-17
RS20050063A (en) 2007-09-21

Similar Documents

Publication Publication Date Title
IS7717A (is) Pýrídasínónafleiður sem PDF4-hemlar
DE60320933D1 (de) Rho-kinase inhibitoren
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
ATE478870T1 (de) Spiroindolinpiperidinderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
ATE517888T1 (de) Indolylmaleimid-derivate
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
ATE438644T1 (de) Chinazolinderivate
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
NO20050665L (no) Pyrrolidonderivater som MAOE inhibitoere
IS7509A (is) Þíoxantínafleiður sem mergperoxídasatálmar
DE602004018837D1 (de) Ptidase-iv-inhibitoren
EP1532133A4 (en) NF-: B INHIBITORS
ATE402700T1 (de) Glycinamid-derivate als raf-kinase-hemmer
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
ITMI20020148A1 (it) Nuovi corticosteroidi
NO20035440D0 (no) Pyrrolidinderivater som faktor-XA-inhibitorer
ATE423771T1 (de) Tetrahydrochinolinderivate
ATE373648T1 (de) Nf-kappab-inhibitoren
IS7696A (is) Pýrrólídínafleiður sem trypsínhemlar
DE60307471D1 (de) Hemmung
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors